http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1330435-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ddadb999be4f451dfc44d8e359d8f6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 2001-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd6bed4630a1fcac97534274f0bebc2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea7e445d43b0d6ca54fc2e294bd0325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a20f34c8d4ec5373ef929c7b3432c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6844296f34af911b50acf6f02f61b06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bc3cc8c7e22a8655cbca4c7ee3839e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30d4f7090b91a43d587a7f25ddd52aad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c808c3217579d38cc840999aab335782
publicationDate 2005-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1330435-B1
titleOfInvention Crystalline forms of fluvastatin sodium
abstract Crystalline forms of the (3R,5S)- and the (3S,5R)-enantiomers of fluvastatin, referred to as polymorphic Forms A, B1, B2, C, D and E, processes for the preparation of these crystalline forms and pharmaceutical compositions comprising them are disclosed.
priorityDate 2000-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227386167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23679527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9954640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127856099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66921416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9932627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127856101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231991921

Total number of triples: 51.